R1 RCM Inc. (“R1”), a leader in technology-driven healthcare solutions, has been named a 2025 ‘Best in KLAS’ award winner in several key categories, underscoring its capabilities in revenue cycle ...

Private equity firms have locked in on revenue cycle management as a good investment opportunity as demand for the services ...

R1 RCM (NASDAQ:RCM) was downgraded to hold from buy at Deutsche Bank after the shares surged 25% on Monday after New Mountain offered to buy the company for $13.75 a share.

The firm sought to buy out revenue cycle management vendor R1 RCM for $5.8 billion last year, though its offer was beat out when other investors took the company private in an $8.9 billion deal.

Her past experience also includes executive roles at Optum, Dallas-based Steward Health Care and Accretive Health (now R1 RCM), according to the release. She has led revenue cycle teams through ...

The RCM company's chairman, Vardhman Jain ... In 2024, New Mountain also unsuccessfully attempted to acquire R1 RCM. Private equity firms TowerBrook Capital Partners and Clayton, Dubilier ...

R1 RCM (NASDAQ:RCM) fell 2.4% in regular trading Thursday at least partly amid a downgrade of the company to neutral at Citi. Citi analyst Daniel Grosslight cut his rating to neutral from buy ...

R1 RCM Inc. (NASDAQ:RCM ... There are multiple factors that make this company a promising investment avenue. To start with, the report for the third quarter of 2024 showed the company’s ability ...

“R1 is the most responsive tech company I have ever worked with ... while a health system CFO remarked in December 2024 that, “R1 RCM has gone above and beyond in the partnership.

"R1 is the most responsive tech company I have ever worked with,” said one healthcare analyst in July 2024 who employs R1's solutions, while a health system CFO remarked in December 2024 that, "R1 RCM ...